{"id":"https://openalex.org/W25156715","doi":null,"title":"[Treatment of generalized anxiety: new pharmacologic approaches].","display_name":"[Treatment of generalized anxiety: new pharmacologic approaches].","publication_year":1995,"publication_date":"1995-11-01","ids":{"openalex":"https://openalex.org/W25156715","mag":"25156715","pmid":"https://pubmed.ncbi.nlm.nih.gov/8674471"},"language":"fr","primary_location":{"id":"pmid:8674471","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8674471","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"L'Encephale","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104507431","display_name":"J.-P. Boulenger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801825082","display_name":"Centre Hospitalier Universitaire de Sherbrooke","ror":"https://ror.org/020r51985","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801825082","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"J P Boulenger","raw_affiliation_strings":["Centre Hospitalier Universitaire de Sherbrooke, Qu\u00e9bec"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier Universitaire de Sherbrooke, Qu\u00e9bec","institution_ids":["https://openalex.org/I2801825082"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5104507431"],"corresponding_institution_ids":["https://openalex.org/I2801825082"],"apc_list":null,"apc_paid":null,"fwci":0.8512,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.69751649,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"6","first_page":"459","last_page":"66"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/generalized-anxiety-disorder","display_name":"generalized anxiety disorder","score":0.9959999918937683},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.8569999933242798},{"id":"https://openalex.org/keywords/5-ht1a-receptor-agonist","display_name":"5-HT1A receptor agonist","score":0.9279999732971191},{"id":"https://openalex.org/keywords/buspirone","display_name":"buspirone","score":0.9399999976158142},{"id":"https://openalex.org/keywords/ipsapirone","display_name":"ipsapirone","score":0.8939999938011169},{"id":"https://openalex.org/keywords/5-ht2-antagonists","display_name":"5-HT2 antagonists","score":0.8339999914169312},{"id":"https://openalex.org/keywords/5-ht3-receptor-antagonists","display_name":"5-HT3 receptor antagonists","score":0.984000027179718},{"id":"https://openalex.org/keywords/ondansetron","display_name":"ondansetron","score":0.9419999718666077},{"id":"https://openalex.org/keywords/abecarnil","display_name":"abecarnil","score":0.9300000071525574},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.7300000190734863},{"id":"https://openalex.org/keywords/benzodiazepine-withdrawal","display_name":"benzodiazepine withdrawal","score":0.5839999914169312},{"id":"https://openalex.org/keywords/somatic-symptoms","display_name":"somatic symptoms","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C2777287423","wikidata":"https://www.wikidata.org/wiki/Q412194","display_name":"Buspirone","level":4,"score":0.8942868709564209},{"id":"https://openalex.org/C2779911313","wikidata":"https://www.wikidata.org/wiki/Q845224","display_name":"Generalized anxiety disorder","level":3,"score":0.8740217685699463},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.6665245294570923},{"id":"https://openalex.org/C2779978724","wikidata":"https://www.wikidata.org/wiki/Q1436482","display_name":"Worry","level":3,"score":0.6545536518096924},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5521596074104309},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.525505781173706},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4530179798603058},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.4526401162147522},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30076485872268677},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.23969244956970215},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1726773977279663},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.118120938539505}],"mesh":[{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005544","descriptor_name":"Forecasting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008134","descriptor_name":"Long-Term Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015990","descriptor_name":"Placebo Effect","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8674471","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8674471","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"L'Encephale","raw_type":"Comparative Study"},{"id":"mag:25156715","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8674471","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W90446778","https://openalex.org/W1482866244","https://openalex.org/W1496107432","https://openalex.org/W1972581901","https://openalex.org/W1978048790","https://openalex.org/W1979561515","https://openalex.org/W1980256159","https://openalex.org/W1980582793","https://openalex.org/W1984850107","https://openalex.org/W1991592049","https://openalex.org/W1999536845","https://openalex.org/W2002611375","https://openalex.org/W2005145546","https://openalex.org/W2017213329","https://openalex.org/W2021722959","https://openalex.org/W2028850807","https://openalex.org/W2029275361","https://openalex.org/W2039745983","https://openalex.org/W2042274346","https://openalex.org/W2048174395","https://openalex.org/W2053505020","https://openalex.org/W2055952108","https://openalex.org/W2057570995","https://openalex.org/W2062623089","https://openalex.org/W2069896987","https://openalex.org/W2079296486","https://openalex.org/W2081797068","https://openalex.org/W2082839348","https://openalex.org/W2082894170","https://openalex.org/W2091135133","https://openalex.org/W2095689320","https://openalex.org/W2098765233","https://openalex.org/W2099564342","https://openalex.org/W2101146042","https://openalex.org/W2108630902","https://openalex.org/W2119030827","https://openalex.org/W2123602911","https://openalex.org/W2126860097","https://openalex.org/W2138271749","https://openalex.org/W2139376220","https://openalex.org/W2148028028","https://openalex.org/W2153340738","https://openalex.org/W2153719039","https://openalex.org/W2162834581","https://openalex.org/W2165561409","https://openalex.org/W2239946482","https://openalex.org/W2320299038","https://openalex.org/W6681839027"],"related_works":["https://openalex.org/W59589068","https://openalex.org/W7054151392","https://openalex.org/W2115352662","https://openalex.org/W1971209851","https://openalex.org/W1733976868","https://openalex.org/W1517490421","https://openalex.org/W4376630644","https://openalex.org/W3142909662","https://openalex.org/W1854968879","https://openalex.org/W7206398382"],"abstract_inverted_index":{"First":[0],"defined":[1],"as":[2,63,136,528],"a":[3,64,89,176,246,288,367,371,564],"residual":[4],"diagnostic":[5,530],"category":[6],"in":[7,123,211,335,355,366,406,410,461,471,509,524,571,581],"the":[8,12,30,38,51,55,58,103,106,113,116,124,161,173,194,198,206,216,221,230,253,256,268,293,309,349,359,364,392,398,420,431,440,456,472,481,495,519,538,568,575,582],"third":[9],"edition":[10,53],"of":[11,17,29,37,44,54,67,91,95,108,115,118,153,163,175,197,224,232,240,258,265,270,295,311,317,388,395,400,423,443,458,474,484,488,497,506,542,562,577,584],"Diagnostic":[13],"and":[14,33,70,80,105,145,214,238,260,282,332,380,477,534],"Statistical":[15],"Manual":[16],"Mental":[18],"Disorders":[19],"(DSM),":[20],"Generalized":[21],"Anxiety":[22],"Disorder":[23],"(GAD)":[24],"was":[25],"until":[26],"recently":[27],"one":[28],"least":[31,34,84],"studied":[32],"clearly":[35,111,227],"conceptualized":[36],"anxiety":[39,476],"disorders.":[40,479],"The":[41],"clinical":[42,188,195,449,511],"definition":[43],"GAD":[45,119,271,341,396,462],"has":[46],"however":[47],"improved":[48],"up":[49],"to":[50,88,192,285,292,303,340,362,553,556,573],"fourth":[52],"DSM":[56],"where":[57],"disorder":[59],"is":[60,245,249,263,319,333,397],"now":[61],"characterized":[62],"chronic":[65,129,421],"state":[66],"apprehensive":[68],"expectation":[69],"uncontrollable":[71],"worry":[72],"concerning":[73,391],"multiple":[74],"daily":[75],"life":[76],"events":[77],"or":[78,97,131,138,242,307,415],"activities":[79],"accompanied":[81],"with":[82,127,202,321],"at":[83,167,205,235],"3":[85],"symptoms":[86,110],"belonging":[87],"list":[90],"six":[92],"common":[93,466],"manifestations":[94],"psychic":[96],"motor":[98],"tension.":[99],"Clinical":[100],"research":[101,551],"demonstrating":[102],"stability":[104],"specificity":[107],"somatic":[109],"support":[112],"validity":[114],"diagnosis":[117,126],"despite":[120],"possible":[121],"difficulties":[122],"differential":[125],"other":[128,151,254,453,547],"conditions":[130],"axis":[132],"II":[133],"disorders":[134],"such":[135,525,527],"dysthymia":[137],"mixed":[139],"anxiety-depressive":[140],"disorder.":[141],"After":[142],"benzodiazepines":[143],"(BZD)":[144],"5-HT1A":[146,376],"agonists":[147,166,377],"like":[148,315,378,383,427],"buspirone,":[149,318],"several":[150],"types":[152,541],"new":[154,276,313,350,389,486,498,578],"anxiolytic":[155,277,499],"drugs":[156,233,278,354,460,500],"have":[157,191,403,492,566],"been":[158],"developed":[159],"for":[160,267,357,439],"treatment":[162,269,394,583],"GAD.":[164,296,585],"Partial":[165],"GABA-BZD":[168],"receptor":[169],"sites":[170],"may":[171,463,515],"offer":[172],"advantage":[174],"better":[177],"efficacy":[178,310,405,457],"vs":[179],"side-effects":[180,244,281],"ratio":[181],"over":[182,330],"classical":[183],"BZDs;":[184],"however,":[185],"systematic":[186],"comparative":[187],"trials":[189,450],"will":[190,299],"demonstrate":[193],"relevance":[196],"encouraging":[199],"results":[200,570],"obtained":[201],"these":[203,280,312,353,425,459,485],"drugs,":[204,314,426],"experimental":[207],"level,":[208],"during":[209,215],"studies":[210],"healthy":[212],"volunteers":[213],"first":[217],"placebo-controlled":[218],"trials.":[219,512],"Furthermore,":[220],"recent":[222,490],"description":[223],"GABA-receptor's":[225],"subunits":[226],"suggest":[228,464],"that":[229,248,316,465,494],"development":[231,257,356,496],"acting":[234,429],"this":[236,407,444],"level":[237],"devoided":[239],"psychomotor":[241],"withdrawal":[243],"target":[247],"worth":[250],"pursuing.":[251],"On":[252],"hand,":[255],"5-HT2":[259],"5-HT3":[261,381],"antagonists":[262,382],"also":[264,300],"interest":[266,483],"since":[272],"it":[273,298],"could":[274],"provide":[275],"without":[279,412],"thus":[283],"easier":[284],"administer":[286],"on":[287,324,430,567],"long-term":[289,441],"basis":[290],"corresponding":[291],"chronicity":[294],"However,":[297,385],"be":[301,434,516,554],"important":[302],"know":[304],"if":[305],"wether":[306],"not":[308,345],"associated":[320],"some":[322],"effects":[323,559],"depressive":[325,413,478],"symptomatology,":[326],"develops":[327],"only":[328],"progressively":[329],"time":[331],"different":[334],"previous":[336],"BZD":[337,347,372,438],"users":[338],"compared":[339],"patients":[342,411],"who":[343],"did":[344],"receive":[346],"before":[348],"drug.":[351],"Among":[352],"GAD,":[358,424,489],"most":[360],"likely":[361],"reach":[363],"market":[365],"near":[368],"future":[369],"are":[370,469],"partial":[373],"agonist":[374],"(abecarnil),":[375],"ipsapirone":[379],"ondansetron.":[384],"another":[386],"area":[387],"developments":[390],"drug":[393],"use":[399],"antidepressants,":[401],"which":[402],"demonstrated":[404],"indication":[408],"even":[409],"features":[414],"panic":[416],"attacks":[417],"symptoms.":[418],"Considering":[419],"nature":[422],"those":[428],"5-HT-system,":[432],"would":[433],"more":[435,550],"adapted":[436],"than":[437,454],"management":[442],"condition.":[445],"If":[446],"confirmed":[447],"by":[448,504,546],"involving":[451],"antidepressants":[452],"tricyclics,":[455],"neurobiological":[467],"mechanisms":[468],"involved":[470],"pathogenesis":[473],"both":[475],"Despite":[480],"potential":[482],"treatments":[487],"years":[491],"shown":[493],"often":[501],"appears":[502],"limited":[503],"high-rates":[505],"placebo":[507],"response":[508],"numerous":[510],"This":[513],"phenomenon":[514],"related--in":[517],"part--to":[518],"increasingly":[520],"sophisticated":[521],"designs":[522],"used":[523],"trials,":[526],"extensive":[529],"workups,":[531],"repeated":[532],"evaluations":[533],"inclusion":[535],"criteria":[536],"selecting":[537],"less":[539],"severe":[540],"anxiety.":[543],"As":[544],"emphasized":[545],"authors,":[548],"much":[549],"needs":[552],"done":[555],"establish":[557],"what":[558],"various":[560],"ways":[561],"conducting":[563],"trial":[565],"trial's":[569],"order":[572],"facilitate":[574],"emergence":[576],"psychopharmacological":[579],"approaches":[580]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}